Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lenalid® Tab - Oncology Injection - Pharmaceuticals - Product Samyang Biopharmaceuticals
Connect with this vendor - Learn about this product

Lenalid® Tab

Lenalid® Tab Lenalidomide/Tab 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg, 25mg Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Mantle Cell Lymphoma (MCL) Increased Patient Compliance Completion of BE Studies Guaranteed Safety of Drug Product